17-43758681-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PM5PP3PP5_Moderate
The NM_025237.3(SOST):c.61G>A(p.Val21Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V21L) has been classified as Pathogenic.
Frequency
Consequence
NM_025237.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SOST | NM_025237.3 | c.61G>A | p.Val21Met | missense_variant | 1/2 | ENST00000301691.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SOST | ENST00000301691.3 | c.61G>A | p.Val21Met | missense_variant | 1/2 | 1 | NM_025237.3 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Craniodiaphyseal dysplasia, autosomal dominant Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | May 01, 2011 | - - |
SOST-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 25, 2023 | The SOST c.61G>A variant is predicted to result in the amino acid substitution p.Val21Met. This variant was reported to occur de novo in an individual with autosomal dominant craniodiaphyseal dysplasia (Kim et al 2011. PubMed ID: 21221996). In addition, an alternative amino acid substitution at this position (c.61G>T, p.Val21Leu) was also reported in a patient with presumed autosomal dominant craniodiaphyseal dysplasia (Kim et al 2011. PubMed ID: 21221996). Functional studies with both variants indicate the p.Val21 residue is part of the secretion signal of the protein and disrupts sclerostin secretion (Kim et al 2011. PubMed ID: 21221996). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at